Summary
66 / 100 · Bulios Score
What speaks for it
- Revenue grew by 38% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 25% this fiscal year.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.9 BRL for 1 BRL of yearly profit. Over the last five years it was 21.5 BRL on average.
Valuation in detailIs it growing?
Yes, fastRevenue (BRL)
Diluted EPS (BRL)
- Analyst estimate
Revenue grew by 67% a year over 5 years. Over the last 3 years it grew by 38% a year. For the next fiscal year analysts expect revenue to fall by 25%.
Growth in detailDoes it make money?
PoorlyWhere 100 BRL of revenue goes
- Cost of sales 60 BRL
- Sales and administration 29 BRL
- Taxes and other 2.1 BRL
- Net profit 9.2 BRL
Net profit, industry median (Banks - Regional) 21 BRL
Out of every 100 BRL of revenue, 9.2 BRL is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.67%
- Paid out of profit
- 17%
- Raised in a row
- 1 year
You receive $0.11 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 2
- Sell 1
Today's price within the analysts' price targets
The average target of $8.8 is 31% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.